Akhalesh Kumar Dube
Research Subjects
Akhalesh Kumar Dube has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Akhilesh Kumar Mishra
School of Pharmacy, Babu Banarasi Das University, Lucknow-226028, Uttar Pradesh, India
1 shared publication - Anit Kumar Jha
Department of Pharmaceutics, Institute of Pharmacy, Madhyanchal Professional University, Bhopal, Madhya Pradesh, India
1 shared publication - Bharat Bhushan
Department of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India
1 shared publication - Ketki Rani
Department of Chemistry, SGT College of Pharmacy, SGT University, Gurugram, Haryana, India
1 shared publication - Kuldeep Singh
Department of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India
1 shared publication - Prateek Porwal
Glocal School of Pharmacy, The Glocal University, Saharanpur, Uttar Pradesh, India
1 shared publication
Latest Publications
- 1 June 2024
- Published by Bentham Science Publishers Ltd. in Letters in Organic Chemistry
- Vol. 21 (6) , 479-492
Harnessing Computational Modeling for Efficient Drug Design Strategies
Computational modeling has become a crucial tool in drug design, offering efficiency and cost-effectiveness. This paper discusses the various computational modeling techniques used in drug design and their role in enabling efficient drug discovery strategies. Molecular docking predicts the binding affinity of a small molecule to a target protein, allowing the researchers to identify potential lead compounds and optimize their interactions. Molecular dynamics simulations provide insights into protein-ligand complexes, enabling the exploration of conformational changes, binding free energies, and fundamental protein-ligand interactions. Integrating computational modeling with machine learning algorithms, such as QSAR modeling and virtual screening, enables the prediction of compound properties and prioritizes potential drug candidates. High-performance computing resources and advanced algorithms are essential for accelerating drug design workflows, with parallel computing, cloud computing, and GPU acceleration reducing computational time. The paper also addresses the challenges and limitations of computational modeling in drug design, such as the accuracy of scoring functions, protein flexibility representation, and validation of predictive models. It emphasizes the need for experimental validation and iterative refinement of computational predictions to ensure the reliability and efficacy of designed drugs.
- 1 June 2024
- Published by Bentham Science Publishers Ltd. in Letters in Organic Chemistry
- Vol. 21 (6) , 479-492
Harnessing Computational Modeling for Efficient Drug Design Strategies
Computational modeling has become a crucial tool in drug design, offering efficiency and cost-effectiveness. This paper discusses the various computational modeling techniques used in drug design and their role in enabling efficient drug discovery strategies. Molecular docking predicts the binding affinity of a small molecule to a target protein, allowing the researchers to identify potential lead compounds and optimize their interactions. Molecular dynamics simulations provide insights into protein-ligand complexes, enabling the exploration of conformational changes, binding free energies, and fundamental protein-ligand interactions. Integrating computational modeling with machine learning algorithms, such as QSAR modeling and virtual screening, enables the prediction of compound properties and prioritizes potential drug candidates. High-performance computing resources and advanced algorithms are essential for accelerating drug design workflows, with parallel computing, cloud computing, and GPU acceleration reducing computational time. The paper also addresses the challenges and limitations of computational modeling in drug design, such as the accuracy of scoring functions, protein flexibility representation, and validation of predictive models. It emphasizes the need for experimental validation and iterative refinement of computational predictions to ensure the reliability and efficacy of designed drugs.